| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b55c349b43c3ecba4977fd52cc8f8c67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aab27872ff881431919b3491fa9b70b4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
2006-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_055d6eccb2e7ce8dfb59863dc95cc447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_023879242ce206a61422b916d0fb805c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1810680fc24fc876041804dab62956ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_011b9c05f47f530f3a7f72f3596d20fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25acf3e13dbb33f4add7dc924338f490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_504c87538cb7fc2899bcc65b455ebcce |
| publicationDate |
2006-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1731143-A1 |
| titleOfInvention |
Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure |
| abstract |
A stable percutaneous absorption-type pharmaceutical preparation for percutaneous administration of selegiline or selegiline hydrochloride, which does not suffer a decrease in the cohesive force of the adhesive layer therein even in the presence of sweat components due to perspiration during wear and which is free from cohesive failure and resultant adhesive remaining when stripped off, is provided. A percutaneous absorption-type pharmaceutical preparation which comprises: a support; and an adhesive layer containing a metal chloride, an adhesive and at least one of (-)-(R)-N,α-dimethyl-N-2-propynylphenethylamine and its hydrochloride, wherein the adhesive layer is subjected to a crosslinking treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102188412-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102188412-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102188410-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102188411-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2298277-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2279740-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2371359-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2364733-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2371360-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011029598-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2279740-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2561042-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2561043-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2561044-C2 |
| priorityDate |
2005-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |